News | December 06, 2025
Briefs: IOL Chemicals & Pharmaceuticals, Ipca Laboratories and Anuh Pharma
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
The partnership aims to combine TQx’s in vivo therapeutic expertise with Kytopen’s continuous flow transfection technology
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
The agreement allows Biocon Biologics to commercialize both its Denosumab biosimilars (Vevzuo and Evfraxy) in Europe starting December 2, 2025
Angelini Ventures has already invested €125 million in 22 startups
Presbyopia, the age-related loss of near vision, could soon be treated successfully
Subscribe To Our Newsletter & Stay Updated
